Phase IIa proof-of-concept trial of CC8464 in patients with peripheral neuropathic pain
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2016
At a glance
- Drugs CC 8464 (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 13 Oct 2016 According to a Chromocell media release, first patient is dosed with CC8464 for the management of neuropathic pain.
- 13 Oct 2016 Status changed from planning to recruiting, according to a Chromocell media release.
- 06 Oct 2015 New trial record